Skip to Content
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 17, Issue 6

2010 November - 18 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (18)

  • Proceeding Paper
  • Open Access
207 Views
6 Pages

1 November 2010

This meeting report is the second in a series by the Terry Fox Research Institute about its Pan-Canadian Dialogue Series on Cancer: Let’s Get Personal, a public research and outreach project. The inaugural dialogue was held in St. John’s, Newfoundlan...

  • Article
  • Open Access
9 Citations
1,139 Views
6 Pages

Cancer Nutrition Rehabilitation Program: The Role of Social Work

  • Diane Townsend,
  • C. Accurso–Massana,
  • C. Lechman,
  • S. Duder and
  • M. Chasen

1 November 2010

The Cancer Nutrition Rehabilitation (CNR) program at the McGill University Health Centre is an interdisciplinary 8-week treatment program offering patients information, education, treatment, and support in areas such as diet, exercise, and rehabilita...

  • Article
  • Open Access
14 Citations
987 Views
5 Pages

1 November 2010

Background: Soft-tissue sarcoma spreads predominantly to the lung. The frequency with which positron-emission tomography (PET) detects metastases not already obvious by chest computed tomography (CT) or clinical examination is currently unclear. Meth...

  • Article
  • Open Access
31 Citations
1,172 Views
9 Pages

Intensive Induction Chemotherapy without Methotrexate in Adult Patients with Localized Osteosarcoma: Results of the Institut Gustave-Roussy Phase II Trial

  • Hazem Assi,
  • G. Missenard,
  • P. Terrier,
  • C. Le Pechoux,
  • S. Bonvalot,
  • D. Vanel,
  • J.B. Meric,
  • T. Tursz and
  • A. LeCesne

1 November 2010

Purpose: To improve outcomes in localized osteosarcoma and to reduce the duration of preoperative chemotherapy, we conducted a phase ii trial assessing the efficacy of an intensive protracted regimen without methotrexate (API-AI regimen) in adolescen...

  • Article
  • Open Access
31 Citations
926 Views
7 Pages

1 November 2010

Introduction: Hepatitis B virus (HBV) reactivation is a recognized complication of chemotherapy. The U.S. Centers for Disease Control and Prevention recommend that all patients be screened for the HBV surface antigen (HBSAG) before chemotherapy. We s...

  • Article
  • Open Access
8 Citations
1,099 Views
7 Pages

Consensus Recommendations for the Use of Anti-EGFR Therapies in Metastatic Colorectal Cancer

  • C. Cripps,
  • Sharlene Gill,
  • S. Ahmed,
  • B. Colwell,
  • S. Dowden,
  • H. Kennecke,
  • J. Maroun,
  • B. Samson,
  • M. Thirlwell and
  • R. Wong

1 November 2010

In January 2010, a panel of Canadian oncologists with particular expertise in colorectal cancer (CRC) gathered to develop a consensus guideline on the use of therapies against the epidermal growth factor receptor (EGFR) in the management of metastati...

  • Article
  • Open Access
2 Citations
1,834 Views
2 Pages

1 November 2010

Earlier this year in Current Oncology, Trop and colleagues added new information to support the claim that screening with magnetic resonance imaging (MRI) for breast cancer is superior—in terms of sensitivity— to routine mammography [...]

  • Article
  • Open Access
10 Citations
791 Views
6 Pages

What Are the Factors that Predict Outcome at Relapse after Previous Esophagectomy and Adjuvant Therapy in High-Risk Esophageal Cancer?

  • E. Yu,
  • P. Tai,
  • R. Malthaner,
  • L. Stitt,
  • G. Rodrigues,
  • R. Dar,
  • B. Yaremko,
  • J. Younus,
  • M. Sanatani and
  • R. Inculet
  • + 3 authors

1 November 2010

Objectives: The present study investigated factors affecting outcome at relapse after previous surgery and adjuvant chemoradiation (CRT) in high-risk esophageal cancer patients. Patients and Methods: From 1989 to 1999, we followed high-risk resected...

  • Article
  • Open Access
27 Citations
1,094 Views
7 Pages

1 November 2010

Purpose: Our survey aimed to document variability in the practice patterns of Canadian radiation oncologists treating high-grade brain tumours. Materials and Methods: A 20-question survey was developed to address various aspects of treatment: (1) Gui...

  • Article
  • Open Access
25 Citations
1,168 Views
6 Pages

1 November 2010

Background: Spontaneous rupture of adrenal pheochromocytoma is an extremely rare condition that can be lethal. Optimal treatment in these cases is still unclear. Methods: We conducted a comprehensive review of MEDLINE articles on ruptured pheochromoc...

  • Article
  • Open Access
6 Citations
841 Views
2 Pages

Arterial Occlusion Precipitated by Cisplatinbased Chemotherapy

  • D. Joseph,
  • Biswajit Dubashi,
  • B. Karthikeyan and
  • A. Jain

1 November 2010

Cisplatin-based therapy is curative in testicular cancer. Adverse effects of cisplatin-based chemotherapy include dose-dependent myelosuppression, nephrotoxicity, neurotoxicity, and ototoxicity. By contrast, chemotherapy-associated vascular complicat...

  • Case Report
  • Open Access
12 Citations
700 Views
5 Pages

Metastatic Carcinoid Presenting as a Breast Lesion

  • Holly L. Geyer,
  • J. Viney and
  • N. Karlin

1 November 2010

Metastasis to the breast is a rare occurrence, constituting fewer than 2% of all breast tumours. Of all metastatic tumours in the breast, most arise from contralateral breast primaries. Other reported primary solid tumour sites include melanoma; lung...

  • Article
  • Open Access
38 Citations
1,242 Views
4 Pages

1 November 2010

Sister Joseph nodule is a metastatic umbilical lesion secondary to a primary malignancy of any viscera. It can be a presenting symptom (a sign of undiagnosed malignancy) or a symptom or sign of progression or recurrence in a known case. Its incidence...

  • Review
  • Open Access
11 Citations
1,062 Views
4 Pages

1 November 2010

Aromatase inhibitors have not been adequately assessed in treatment of ovarian cancer. The aromatase inhibitor letrozole (2.5 mg daily) was administered in 2 cases of advanced endometrioid ovarian cancer with positive estrogen receptor. Case 1: A 52-...

  • Short Communication
  • Open Access
5 Citations
905 Views
3 Pages

Consent to External-Beam Radiotherapy

  • Carolyn Freeman,
  • H. Lamed,
  • C. Gingras and
  • G. Shenouda

1 November 2010

Canadian law, and the physician’s code of ethics, requires that informed consent be obtained before any medical act is performed. However, there are no rules about how consent is to be obtained and by whom, and how that consent is to be documented. I...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729